周围炎症是阿尔茨海默氏症疾病潜在的病因因素
Ziyuan Li1, Hui Wang1, Yafu Yin1
1Department of Nuclear Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Kongjiang Road 1665, Yangpu District, Shanghai 200092, China.
Reviews in the neurosciences
|August 21, 2023
概括
外周炎症和感染与阿尔茨海默病 (AD) 有关. 早期的抗炎干预可以通过准这些关联来帮助预防和治疗AD.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 外周炎症越来越被认为是阿尔茨海默氏症 (AD) 的潜在危险因素.
- 许多病原体和慢性炎症状况与AD病理生理学有关.
研究的目的:
- 审查和总结关于外周炎症和阿尔茨海默病之间的关系的研究.
- 探索将外周炎症与AD发展和进展联系起来的机制.
主要方法:
- 对关于外周炎症和AD的现有文献进行系统审查.
- 对研究特定病原体和与AD相关的慢性炎症疾病的分析.
- 检查拟议的机制,包括病原体衍生的毒素,血脑屏障的破坏和神经生成功能障碍.
主要成果:
- 在AD和各种病原体感染之间发现了显著的关联 (例如HSV-1,CMV,EBV,HIV,SARS-CoV-2,P. gingivalis,H. pylori,T. gondii).
- 慢性炎症疾病也会导致AD的病理生理学.
- 机制包括神经毒性分子,受损的血脑屏障和神经发生障碍.
结论:
- 由感染和慢性疾病驱动的外周炎症在阿尔茨海默病中起着复杂的作用.
- 抗病原和抗炎疗法显示出降低AD风险的潜力.
- 需要进一步的研究来阐明这些关联,支持早期干预策略来预防和治疗AD.
相关概念视频
Alzheimer's Disease: Overview
518
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213


